Skip to content
PeptideTech
Cart

Home / Research library / Dermorphin

Peptides

Dermorphin: molecular data, studies & sources

Dermorphin is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF)
C40H50N8O10
Molecular weight (MW)
802.9 g/mol
PubChem compound ID
5485199
Record title
Dermorphin

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 5485199 · retrieved 2026-09-21

2D molecular structure for Dermorphin, PubChem CID 5485199
2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.
Chemical identifiers and source data
IUPAC name
(2S)-N-[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]-1-[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxamide
InChIKey
FHZPGIUBXYVUOY-VWGYHWLBSA-N
SMILES
C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N
Machine-readable PubChem source

Identifiers & sequence

PubChem CID
5485199
CAS Registry Number
77614-16-5via ChemIDplus, EPA DSSTox, FDA GSRS
FDA UNII
2SEC01B703
ChEMBL ID
CHEMBL278789
InChIKey
FHZPGIUBXYVUOY-VWGYHWLBSA-N
Wikidata
Q1771654

Peptide sequence · 7 residues (one-letter code; X marks a residue without a one-letter code)

YAFGYPS

Condensed notation with terminal groups and non-standard residues

H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2

Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.

CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.

Calculated molecular descriptors
Monoisotopic (exact) mass802.3650 Da
Heavy atoms58
Hydrogen-bond donors10
Hydrogen-bond acceptors11
Rotatable bonds19
Topological polar surface area295.6 Ų
Calculated logP (Crippen)-2.00
Rings4
Stereocenters6
Formal charge0

Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.

Registered clinical trials

Studies registered on ClinicalTrials.gov that list Dermorphin as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received Dermorphin, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

  1. Human study · PubMed trial index Compound given to participants

    Prolactin-releasing activity of dermorphin, a new synthetic potent opiate-like peptide, in normal human subjects.

    Degli Uberti EC, Trasforini G, Salvadori S et al. · The Journal of clinical endocrinology and metabolism · 1983

    PMID 6833466 · DOI: 10.1210/jcem-56-5-1032

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.

    Dermorphin supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    Dermorphin for sale: compare prices, sizes and forms from every tracked supplier →

    SupplierRecorded packagesExample source listing
    Cenexa LabsUSD5mg Vial1 recorded offers5mg Vial · $129.99Checked Oct 12, 2026Supplier listing, Dermorphin 5mg Vial, Cenexa Labs, opens in a new tab

    Reference sources & further reading

    The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

    Search for additional research

    These links run searches; their results have not been individually reviewed and can include unrelated compounds.

    Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

    Related research profiles

    Other compounds

    AICAR

    C9H14N4O5

    258.23 g/mol · PubChem CID 17513

    4 selected publications · 3 human intervention studies · 4 registered trials

    Small molecule · highest stage: Phase 3

    Structure, studies & sources →

    Other compounds

    Enclomiphene

    C26H28ClNO

    406.0 g/mol · PubChem CID 1548953

    5 selected publications · 3 human intervention studies · 22 registered trials

    Small molecule · highest stage: Phase 3

    Structure, studies & sources →